---
title: "Shandong Xinhua Pharmaceutical Ends Equity Acquisition Talks with NovoSana"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/275106083.md"
description: "Shandong Xinhua Pharmaceutical Company Limited has terminated its equity acquisition talks with NovoSana (Europe) B.V. due to an inability to reach a consensus on the agreement's terms. The company confirmed that this decision will not impact its current operations or development."
datetime: "2026-02-06T09:47:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275106083.md)
  - [en](https://longbridge.com/en/news/275106083.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275106083.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/275106083.md) | [繁體中文](https://longbridge.com/zh-HK/news/275106083.md)


# Shandong Xinhua Pharmaceutical Ends Equity Acquisition Talks with NovoSana

Shandong Xinhua Pharmaceutical Company Limited has decided to terminate its previously announced equity acquisition intention agreement with NovoSana (Europe) B.V. The company cited that, despite initial friendly negotiations, the parties were unable to reach a consensus on the terms and conditions of a formal agreement. As a result, the project will not proceed. The company stated that this decision will not affect its current operations or development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Xinhua Pharmaceutical Company Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260206-12017960), on February 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [Xinhua Pharm (000756.CN)](https://longbridge.com/en/quote/000756.CN.md)
- [SHANDONG XINHUA (00719.HK)](https://longbridge.com/en/quote/00719.HK.md)

## Related News & Research

- [Pharmaceutical Technology’s parent company GlobalData moves to Main Market of LSE](https://longbridge.com/en/news/277928514.md)
- [CordenPharma leases space at Flatiron Park for peptides development](https://longbridge.com/en/news/277929711.md)
- [CanSino Biologics Wins PIC/S GMP Nod for Key Conjugate Vaccines](https://longbridge.com/en/news/277909067.md)
- [13:50 ETNejvětší farmaceutický veletrh v Asii se v červnu 2026 vrátí do Šanghaje](https://longbridge.com/en/news/277666717.md)
- [18:33 ETSunwave presenta un sitio todo en uno en el MWC Barcelona 2026 que ofrece conectividad 5G en 30 minutos](https://longbridge.com/en/news/278180929.md)